Accuray Inc reports results for the quarter ended March 31 - Earnings Summary
30/04/2025 22:02
Accuray Inc ARAY.OQ reported a quarterly adjusted loss of 1 cent per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -6 cents. The mean expectation of four analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -9 cents to -2 cents per share. Revenue rose 12% to $113.24 million from a year ago; analysts expected $101.53 million. Accuray Inc's reported EPS for the quarter was a loss of 1 cent. The company reported a quarterly loss of $1.3 million. Accuray Inc shares had fallen by 9.5% this quarter and lost 18.2% so far this year. FORECAST CHANGES The mean earnings estimate of analysts had fallen by about 900% in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy." Wall Street's median 12-month price target for Accuray Inc is $6.00 This summary was machine generated from LSEG data April 30 at 09:02 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Mar. 31 2025 | -0.05 | -0.01 | Beat |
| Dec. 31 2024 | -0.02 | 0.02 | Beat |
| Sep. 30 2024 | -0.05 | -0.04 | Beat |
| Jun. 30 2024 | 0.03 | 0.03 | Met |